Home > Insider Trading > Filing (0000899243-20-032676)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1739104	Elanco Animal Health Inc	ELAN	Pharmaceutical Preparations (2834)	1231

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1144145	Aktiengesellschaft Bayer	Kaiser-Wilhelm-Allee 1 Leverkusen 2M D-52368		No	No	Yes	No
1820027	B.v. Investments World Bayer	Energieweg 1 Mijdrecht P7 3641		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-12-03	54,500,000	$29.84	18,446,429	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Footnotes

Pursuant to an underwriting agreement, dated November 30, 2020, and in connection with the registered public offering of shares of common stock of the Issuer ("Common Stock") pursuant to the prospectus, dated as of January 21, 2020 and filed with the U.S. Securities and Exchange Commission (the "SEC") on January 21, 2020 and the prospectus supplement dated as of November 30, 2020 and filed with the SEC on December 2, 2020, which offering settled on December 3, 2020, Bayer World Investments B.V. sold 54,500,000 shares of Common Stock.
The securities reported as sold were, and those reported as held after the transaction are, held directly by Bayer World Investments B.V., which is an indirect wholly owned subsidiary of Bayer Aktiengesellschaft. Bayer Aktiengesellschaft may be deemed to beneficially own the shares of the Issuer's Common Stock beneficially owned by Bayer World Investments B.V.